Ignite Creation Date:
2024-05-19 @ 5:33 PM
Last Modification Date:
2024-10-26 @ 3:30 PM
Study NCT ID:
NCT06419621
Status:
RECRUITING
Last Update Posted:
2024-05-28
First Post:
2024-05-14
Brief Title:
PM8002 or Placebo Plus Nab-Paclitaxel as First-line Treatment in Inoperable Locally AdvancedMetastatic Triple-negative Breast Cancer
Sponsor:
Organization:
Biotheus Inc